REG - Aquis Exchange PLC - Director/PDMR Notification

Aquis ExchangeAnnouncement

25/11/2021 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211125:nRSY5225Ta&default-theme=true

RNS Number : 5225T  Aquis Exchange PLC  25 November 2021

25 November 2021

 

Aquis Exchange PLC ("Aquis Exchange")
Director/PDMR Notification

Aquis Exchange PLC makes the following announcement regarding its Directors'
participation in the Aquis Share Incentive Plan.

 1.  Details of PDMR / person closely associated with them ("PCA")
 a)  Name                                     Alasdair Haynes
 2.  Reason for the notification
 b)  Position / status                        CEO
 c)  Initial notification / amendment         Initial notification
 3.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                     Aquis Exchange PLC
 b)  LEI                                      213800IXJSF5E1SIW150
 4.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument  Ordinary Shares of 10p each

     Identification Code

                                              GB00BD5JNK30
 b)  Nature of the transaction                Alasdair Haynes participated in the Aquis Share Incentive Plan ("SIP"). The
                                              SIP is a HMRC approved tax-advantaged all-employee share scheme. Under it,
                                              employees are able to purchase ordinary shares at market value using
                                              deductions from salary, and receive allocations of matching and free ordinary
                                              shares. These ordinary shares are held by the employee benefit trust for the
                                              SIP.
 c)  Price(s) and volume(s)                   Price(s)  Volume(s)

                                        655p      1,374

 

 d)  Aggregated information

     -     Aggregated volume

                                                 1,374

      -      Price

                                                  655p

 e)  Date of the transaction                  23 November 2021
 f)  Place of the transaction                 London Stock Exchange, AIM Market (XLON)

 

d)

Aggregated information

-     Aggregated volume

 

 -      Price

 

 

   1,374

 

 

    655p

 

e)

Date of the transaction

23 November 2021

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 1.  Details of PDMR / person closely associated with them ("PCA")
 a)  Name                                     Jonathan Clelland
 2.  Reason for the notification
 a)  Position / status                        CFO & COO
 b)  Initial notification / amendment         Initial notification
 3.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                     Aquis Exchange PLC
 b)  LEI                                      213800IXJSF5E1SIW150
 4.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument  Ordinary Shares of 10p each

     Identification Code

                                              GB00BD5JNK30
 b)  Nature of the transaction                Jonathan Clelland participated in the Aquis Share Incentive Plan ("SIP"). The
                                              SIP is a HMRC approved tax-advantaged all-employee share scheme. Under it,
                                              employees are able to purchase ordinary shares at market value using
                                              deductions from salary, and receive allocations of matching and free ordinary
                                              shares. These ordinary shares are held by the employee benefit trust for the
                                              SIP.
 c)  Price(s) and volume(s)                   Price(s)  Volume(s)

                                        655p      1,374

 

 d)  Aggregated information

     -     Aggregated volume

                                                 1,374

     -        Price

                                                  655p

 e)  Date of the transaction                  23 November 2021
 f)  Place of the transaction                 London Stock Exchange, AIM Market (XLON)

 

d)

Aggregated information

-     Aggregated volume

 

-        Price

 

 

   1,374

 

 

    655p

 

e)

Date of the transaction

23 November 2021

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

Enquiries:

 Aquis Exchange PLC                                            Tel: +44 (0) 7768 078 110
 Belinda Keheyan, Head of Marketing

 Liberum Capital Limited (Nominated Adviser and Joint Broker)  Tel: +44 (0) 20 3100 2000
 Chris Clarke
 Clayton Bush
 Edward Thomas
 Kane Collings

 Canaccord Genuity Limited (Joint Broker)                      Tel: +44 (0) 20 7523 8000
 Bobbie Hilliam (Corporate Broking)

 Alma PR (Financial PR Adviser)                                Tel: +44 (0)20 3405 0209
 Susie Hudson                                                  aquis@almapr.co.uk
 Kieran Breheny
 Faye Calow

 

Notes to Editors

Aquis Exchange PLC is an exchange services group, which operates pan-European
cash equities trading businesses (Aquis Exchange/AQX), growth and regulated
primary markets (Aquis Stock Exchange/AQSE) and develops/licenses exchange
software to third parties (Aquis Technologies).

Aquis Exchange (AQX) is authorised and regulated by the UK Financial Conduct
Authority and France's Autorité des Marchés Financiers to operate
Multilateral Trading Facility businesses in the UK/Switzerland and in EU27
respectively. AQX operates lit order books and does not allow aggressive
non-client proprietary trading, which has resulted in lower market impact and
signalling risk on AQX than other trading venues in Europe. According to
independent studies, trades on Aquis are less likely to lead to price movement
than on other lit markets. AQX uses a subscription pricing model which works
by charging users according to the message traffic they generate, rather than
a percentage of the value of each stock that they trade.

Aquis Stock Exchange (AQSE) is a stock market providing primary and secondary
markets for equity and debt products. It is authorised as a Recognised
Investment Exchange, which allows it to operate a regulated listings venue.
The AQSE Growth Market is divided into two segments 'Access' and 'Apex', with
different levels of admission criteria. The Access market focuses on earlier
stage growth companies, while Apex is the intended market for larger, more
established businesses.

Aquis Technologies is the software and technology division of Aquis Exchange
PLC. It creates and licenses cutting-edge, cost-effective matching engine and
trade surveillance technology for banks, brokers, investment firms and
exchanges.

Aquis Exchange PLC (AQX.L) is listed on the Alternative Investment Market of
the LSE (AIM) market. For more information, please go to  www.aquis.eu
(https://protect-eu.mimecast.com/s/J6W1CWLkXujqqGXTx7PAm?domain=aquis.eu)

For more information, please go to www.aquis.eu  (http://www.aquis.eu/)
and www.aquis.technology (http://www.aquis.technology/)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFFFLLLELSFIL